Fatal Rickettsia conorii subsp. israelensis Infection, Israel
Miriam Weinberger*† , Avi Keysary‡, Judith Sandbank*, Ronit Zaidenstein*, Avi Itzhaki*, Carmela Strenger‡, Moshe Leitner‡, Christopher D. Paddock§, and Marina E. Eremeeva§
Author affiliations: *Assaf Harofeh Medical Center, Zerifin, Israel; †Tel Aviv University, Ramat Aviv, Israel; ‡Israel Institute for Biological Research, Ness-Ziona, Israel; §Centers for Disease Control and Prevention, Atlanta, Georgia, USA;
Figure 2. PCR product from the 17-kDa protein antigen gene obtained from DNA extracted from necropsied tissues of the patient. Primary PCR (A), nested PCR (B), and BfaI restriction enzyme pattern of the 17-kDa protein gene amplicon (C). Lane 1, reagent control; 2, skin; 3, liver; 4, lung; NTC, nontemplate control; SF, Rickettsia conorii DNA control; SM, size markers.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.